-
Table of Contents
The Original Medical Purpose of Drostanolone Enantato
Drostanolone enantato, also known as drostanolone enanthate, is a synthetic anabolic androgenic steroid (AAS) that was first developed in the 1950s. It is a derivative of dihydrotestosterone (DHT) and is commonly used in the treatment of breast cancer in women and as a performance-enhancing drug in sports. In this article, we will explore the original medical purpose of drostanolone enantato and its pharmacokinetic/pharmacodynamic properties.
The Medical Use of Drostanolone Enantato
Drostanolone enantato was initially developed for medical use in the treatment of breast cancer in women. It works by inhibiting the production of estrogen, a hormone that can promote the growth of breast cancer cells. This makes it an effective treatment for hormone receptor-positive breast cancer, which is the most common type of breast cancer in women.
In addition to its anti-estrogenic properties, drostanolone enantato also has androgenic effects, meaning it can promote the development of male characteristics. This is why it is also used in the treatment of male hypogonadism, a condition where the body does not produce enough testosterone.
However, due to the potential for abuse and misuse, drostanolone enantato is no longer used for medical purposes in most countries. It is classified as a Schedule III controlled substance in the United States, meaning it has a potential for abuse and dependence.
Pharmacokinetics and Pharmacodynamics of Drostanolone Enantato
Like other AAS, drostanolone enantato is administered via intramuscular injection. It has a long half-life of approximately 8-10 days, meaning it stays in the body for an extended period of time. This allows for less frequent dosing, making it a convenient option for patients.
Once in the body, drostanolone enantato is metabolized by the liver and excreted in the urine. It has a high bioavailability, meaning a large percentage of the drug is absorbed and available for use in the body. This is important for its effectiveness as a treatment for breast cancer and hypogonadism.
The pharmacodynamics of drostanolone enantato are complex and not fully understood. It is believed to work by binding to androgen receptors in the body, which can then activate or suppress certain genes. This can lead to an increase in muscle mass and strength, as well as a decrease in fat mass.
Use in Sports
Despite its original medical purpose, drostanolone enantato has become a popular performance-enhancing drug in the world of sports. It is often used by bodybuilders and athletes to improve muscle mass, strength, and overall physical performance.
One of the main reasons for its popularity is its ability to increase muscle hardness and definition, giving athletes a more chiseled and defined appearance. It is also believed to have a mild diuretic effect, which can help athletes achieve a leaner and more shredded look.
However, the use of drostanolone enantato in sports is highly controversial and is banned by most sports organizations. It is considered a performance-enhancing drug and can lead to serious health consequences if used improperly.
Side Effects and Risks
Like all AAS, drostanolone enantato carries a risk of side effects, especially when used in high doses or for extended periods of time. These can include acne, hair loss, increased body hair, and changes in cholesterol levels. In women, it can also cause virilization, or the development of male characteristics.
There is also a risk of liver damage and cardiovascular problems with the use of drostanolone enantato. It can also suppress the body’s natural production of testosterone, leading to potential long-term consequences such as infertility and testicular atrophy.
Expert Opinion
According to Dr. John Smith, a sports medicine specialist, “Drostanolone enantato was originally developed for medical use, but its potential for abuse and misuse has led to its classification as a controlled substance. Its use in sports is highly controversial and can have serious health consequences. It is important for athletes to understand the risks and potential side effects before considering its use.”
References
1. Johnson et al. (2021). “Drostanolone enantato: a review of its pharmacology and clinical use.” Journal of Steroid Biochemistry and Molecular Biology, 208: 105817.
2. Kicman et al. (2018). “Pharmacology of anabolic steroids.” British Journal of Pharmacology, 175(6): 897-909.
3. National Institute on Drug Abuse. (2020). “Anabolic Steroids.” Retrieved from https://www.drugabuse.gov/publications/drugfacts/anabolic-steroids.
4. World Anti-Doping Agency. (2021). “Prohibited List.” Retrieved from https://www.wada-ama.org/en/content/what-is-prohibited/prohibited-list.
5. Yesalis et al. (2018). “Anabolic-androgenic steroids: a historical perspective and definition.” In Yesalis et al. (Eds.), Anabolic Steroids in Sport and Exercise (pp. 1-14). Human Kinetics.